509
Participants
Start Date
March 2, 2020
Primary Completion Date
November 9, 2021
Study Completion Date
September 28, 2022
Bimekizumab
Subjects will receive bimekizumab at pre-specified time-points.
Placebo
Subjects will receive placebo at pre-specified time-points during the Initial Treatment Period.
Hs0004 50150, Philadelphia
Hs0004 50179, Winston-Salem
Hs0004 50211, Durham
Hs0004 50084, Johns Island
Hs0004 50236, Greenville
Hs0004 50193, Sandy Springs
Hs0004 50223, Savannah
Hs0004 50152, Orange Park
Hs0004 50184, Pembroke Pines
Hs0004 50199, Miami
Hs0004 50144, Orlando
Hs0004 50145, Columbus
Hs0004 50202, Fairborn
Hs0004 50234, Plainfield
Hs0004 50178, Clarkston
Hs0004 50164, Skokie
Hs0004 50105, St Louis
Hs0004 50148, Pflugerville
Hs0004 50237, Albuquerque
Hs0004 50197, Henderson
Hs0004 50196, Thousand Oaks
Hs0004 50162, Fountain Valley
Hs0004 50159, Portsmouth
Hs0004 50200, Verona
Hs0004 30018, Parkville
Hs0004 30014, St Leonards
Hs0004 30009, Westmead
Hs0004 40313, Pleven
Hs0004 40284, Sofia
Hs0004 40311, Sofia
Hs0004 40314, Sofia
Hs0004 40315, Sofia
Hs0004 40353, Stara Zagora
Hs0004 50172, Cobourg
Hs0004 50135, Edmonton
Hs0004 50174, London
Hs0004 50189, St. John's
Hs0004 50134, Waterloo
Hs0004 50136, Winnipeg
Hs0004 40063, Prague
Hs0004 40194, Prague
Hs0004 40245, Antony
Hs0004 40321, Auxerre
Hs0004 40129, Bordeaux
Hs0004 40320, La Rochelle
Hs0004 40247, Lyon
Hs0004 40130, Marseille
Hs0004 40404, Reims
Hs0004 40403, Saint-Etienne
Hs0004 40286, Toulouse
Hs0004 40289, Berlin
Hs0004 40326, Berlin
Hs0004 40322, Dessau
Hs0004 40356, Dresden
Hs0004 40287, Frankfurt am Main
Hs0004 40142, Hamburg
Hs0004 40328, Hanover
Hs0004 40250, Lübeck
Hs0004 40254, Debrecen
Hs0004 40344, Dublin
Hs0004 20090, Afula
Hs0004 20196, Bunkyō City
Hs0004 20144, Fukuoka
Hs0004 20043, Itabashi-ku
Hs0004 20195, Kagoshima
Hs0004 20170, Kurume
Hs0004 20190, Kyoto
Hs0004 20033, Nagoya
Hs0004 20152, Nakagami-gun
Hs0004 20178, Nishinomiya
Hs0004 20153, Obihiro
Hs0004 20037, Osaka
Hs0004 20154, Sapporo
Hs0004 20171, Sendai
Hs0004 40347, Lodz
Hs0004 40293, Rzeszów
Hs0004 40335, Warsaw
Hs0004 40095, Wroclaw
Hs0004 40333, Wroclaw
Hs0004 40334, Wroclaw
Hs0004 40159, Barcelona
Hs0004 40267, Barcelona
Hs0004 40298, Granada
Hs0004 40268, Madrid
Hs0004 40297, Manises
Hs0004 40101, Sabadell
Hs0004 40300, Cardiff
Hs0004 40339, Leeds
Hs0004 40113, London
Hs0004 40240, Newcastle upon Tyne
Hs0004 40338, Northampton
UCB Biopharma SRL
INDUSTRY